Adaptive Radiation Therapy for Head & Neck Cancer Patients
Status: | Recruiting |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/16/2015 |
Start Date: | August 2009 |
End Date: | February 2020 |
Contact: | Kenneth Hu, MD |
Email: | Khu@chpnet.org |
Phone: | 2128448087 |
Kilovoltage Conebeam Imaging Based Adaptive Radiation Therapy for Head & Neck Patients Treated With Intensity Modulated Radiation Therapy
The purpose of this study is to determine the utility of kilovoltage (kV) cone beam CT
imaging to track the dose delivered in head and neck cancer patients, to assess the benefit
of cone beam CT to patients set-up for radiation treatment, to determine how shifts based on
kV cone beam CT compare to the standard approach (orthogonal pair), and to develop remote
access tools (preferably internet-based) so that the MD can approve these plans in real
time.
imaging to track the dose delivered in head and neck cancer patients, to assess the benefit
of cone beam CT to patients set-up for radiation treatment, to determine how shifts based on
kV cone beam CT compare to the standard approach (orthogonal pair), and to develop remote
access tools (preferably internet-based) so that the MD can approve these plans in real
time.
The investigators' secondary objectives for this study are to assess the possibility of
using kV cone beam for treatment replanning as compared to standard the treatment planning,
to determine the need and feasibility of adaptive radiation therapy, to develop concept of
establishing cumulative DVH (C-DVH) with daily updates and compare it to planned DVH
(P-DVH), to identify tolerance margins, to evaluate local control, locoregional control,
distant metastasis, and overall survival, to assess patient quality of life,and to develop
predictors of patients which may benefit from ART.
using kV cone beam for treatment replanning as compared to standard the treatment planning,
to determine the need and feasibility of adaptive radiation therapy, to develop concept of
establishing cumulative DVH (C-DVH) with daily updates and compare it to planned DVH
(P-DVH), to identify tolerance margins, to evaluate local control, locoregional control,
distant metastasis, and overall survival, to assess patient quality of life,and to develop
predictors of patients which may benefit from ART.
Inclusion Criteria:
- Patients should have an ECOG (Eastern Clinical Oncology Group) performance status of
0-2
- Patients should meet at least one of the following criteria:
1. Locally advanced cancer (T3-T4 and/or N2-N3)
2. Tumors wrapping around critical structures such as the optic nerves, optic
chiasm, or brainstem
3. Significant expected weight loss.
Exclusion Criteria:
- Previous surgical procedure more significant than a biopsy to the primary tumor or
regional lymph nodes.
- Poor renal function (inability to undergo a CT with IV contrast)
- Previous radiation therapy to the head and neck.
- Inability to tolerate prolonged immobilization.
- Children and women who are pregnant or decline to use contraception.
We found this trial at
2
sites
Beth Israel Med Ctr The physicians and staff of Mount Sinai Beth Israel's Heart Institute...
Click here to add this to my saved trials
Beth Israel Med Ctr The physicians and staff of Mount Sinai Beth Israel's Heart Institute...
Click here to add this to my saved trials